Skip to content
Researchers & MIT Community
Protect
Submit Disclosure
IPIA & Ownership
Understanding Intellectual Property
Tangible Property Licensing
Software & Open Source Protection
Learn
Technology Transfer Overview
Patenting & Commercializing Your Invention
Choosing Vendors & Merchandise
Learn More about IP
Connect
Connect with Your Licensing Officer
Office Hours
Events
Contact Us
Industry & Entrepreneurs
License
Browse Available Technologies
Technology Portfolios
Start the Licensing Process
License MIT’s Trademark
Understanding Expedited Licenses
Learn
Understanding the Licensing Process
Entrepreneurs & Startups
Meet MIT Researchers
Browse Startups
Learn More about IP
Connect
Connect with a Licensing Officer
Contact Us
Impact
About
Our Team
Join Our Mailing List
Annual Reports
Career Opportunities & Internships
FAQs
Submit Disclosure
Browse Technologies
Understand IP
Resources
News
Events
Our Team
Contact
Search
Content type
Search technologies only
Researchers & MIT Community
Protect
Submit Disclosure
IPIA & Ownership
Understanding Intellectual Property
Tangible Property Licensing
Software & Open Source Protection
Learn
Technology Transfer Overview
Patenting & Commercializing Your Invention
Choosing Vendors & Merchandise
Learn More about IP
Connect
Connect with Your Licensing Officer
Office Hours
Events
Contact Us
Industry & Entrepreneurs
License
Browse Available Technologies
Technology Portfolios
Start the Licensing Process
License MIT’s Trademark
Understanding Expedited Licenses
Learn
Understanding the Licensing Process
Entrepreneurs & Startups
Meet MIT Researchers
Browse Startups
Learn More about IP
Connect
Connect with a Licensing Officer
Contact Us
Impact
About
Our Team
Join Our Mailing List
Annual Reports
Career Opportunities & Internships
FAQs
Submit Disclosure
Browse Technologies
Understand IP
Resources
News
Events
Our Team
Contact
Search
Content type
Search technologies only
Develop New Lethal Mutagens for Viral
Diseases
Technology /
Case number:
#16089
John M Essigmann / Katherine Silvestre / Deyu Li
Technology Areas:
Biotechnology / Therapeutics
Impact Areas:
Healthy Living
License
Production of Stable Non-Polyadenylated
RNAs
Technology /
Case number:
#15860
Phillip Sharp / Jeremy Wilusz
Technology Areas:
Biotechnology / Drug Delivery
Impact Areas:
Healthy Living
License
Thiol-yne Mediated Synthesis of Multi-Tailed Lipids for siRNA
Delivery
Technology /
Case number:
#15846
Robert Langer / Akinleye Alabi / Kevin Love / Daniel Anderson
Technology Areas:
Biotechnology / Drug Delivery / Therapeutics
Impact Areas:
Healthy Living
License
Programmable Drug Delivery Profiles of Tumor-Targeted
Bacteria
Technology /
Case number:
#15818H
Sangeeta Bhatia / Tal Danino
Technology Areas:
Biotechnology / Therapeutics
Impact Areas:
Healthy Living
License
Nanofluidic Sorting System for Gene Synthesis & PCR Reaction
Products
Technology /
Case number:
#15517L
Peter Carr / Tarun Jain / Carlos Aguilar / Rohit N Karnik
Technology Areas:
Biotechnology / Chemicals & Materials
Impact Areas:
Healthy Living
License
1,3,5-triazinane-2,4,6-trione (TNT) Derivatives and Uses
Thereof
Technology /
Case number:
#15446
Robert Langer / Hao Yin / Akinleye Alabi / Joseph Dorkin / Ahmed Eltoukhy / Yizhou Dong / Delai Chen / Daniel Anderson
Technology Areas:
Biotechnology / Therapeutics
Impact Areas:
Healthy Living
License
A Single-Walled Carbon Nano-Tube/Chitosan Hydrogel Array for the Label-Free, Optical Detection of Protein-Protein
Interactions
Technology /
Case number:
#14201
Michael S. Strano / Nigel Reuel / Jin Ho Ahn / Paul Barone / Jong Ho Kim
Technology Areas:
Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Sensing & Imaging / Therapeutics
Impact Areas:
Healthy Living
License
Ligand-Inducible Post-Transcriptional Gene Regulation Using Protein-Binding RNA
Aptamers
Technology /
Case number:
#13998J
Brian Belmont / Michael Marletta / Jacquin Niles / Stephen Goldfless
Technology Areas:
Biotechnology / Drug Discovery and Research Tools / Therapeutics
Impact Areas:
Healthy Living
License
DIAL: Programmable Promoter Editing to Generate Defined, Heritable Setpoints of Gene
Expression
Technology /
Case number:
#25874
Katie Galloway / Yunbeen Bae / Sneha Kabaria
Technology Areas:
Biotechnology / Therapeutics
Impact Areas:
Healthy Living
License
One-Step Construction of Allogeneic CAR-NK Cells with Increased Anti-Tumor Cytotoxicity and Resistant to Rejection by Host T Cells and NK
Cells
Technology /
Case number:
#25757J
Jianzhu Chen / Fuguo Liu / Rizwan Romee
Technology Areas:
Biotechnology / Therapeutics
Impact Areas:
Healthy Living
License
Pagination
Previous page
‹‹
Page 3
Next page
››
Subscribe to DNA & RNA Editing